대한한방내과학회지 (The Journal of Internal Korean Medicine)

대한한방내과학회 (The Society of Internal Korean Medicine)
권호 표지

귀전우, 백화사설초, 와송 추출물을 처치한 난소암과 자궁경부암 세포에서의 단백질 발현 변화

Altered Protein Expression in Ovarian and Cervical Cancer Cells by the Treatment of Extracts from Euonymus alatus Sieb, Oldenlandia diffusa (Willd.) Roxburgh, and Orostachys japonicus A. Berger

  • 김경순 (대전대학교 둔산한방병원 동서암센터) ;
  • 예성철 (국립암센터 연구소) ;
  • 유병철 (국립암센터 연구소) ;
  • 조종관 (대전대학교 둔산한방병원 동서암센터) ;
  • 이연월 (대전대학교 둔산한방병원 동서암센터) ;
  • 유화승 (대전대학교 둔산한방병원 동서암센터)
  • Kim, Kyung-Soon (East-West Cancer Center, Dunsan Oriental Medical Hospital, Dae-Jeon University) ;
  • Yea, Sung-Chul (Research Institute, National Cancer Center) ;
  • Yoo, Byong-Chul (Research Institute, National Cancer Center) ;
  • Cho, Chong-Kwan (East-West Cancer Center, Dunsan Oriental Medical Hospital, Dae-Jeon University) ;
  • Lee, Yeon-Weol (East-West Cancer Center, Dunsan Oriental Medical Hospital, Dae-Jeon University) ;
  • Yoo, Hwa-Seung (East-West Cancer Center, Dunsan Oriental Medical Hospital, Dae-Jeon University)
  • 발행 : 2011.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background : Despite recent advances in cancer management, prognosis of ovarian cancer is poor. Anticancer effects of herbal medicine, such as Euonymus alatus Sieb, Oldenlandia diffusa (Willd.) Roxburgh, and Orostachys japonicus A. Berger, have been reported in treatment of ovarian and cervical cancers, but the systematic approaches to explain their molecular mechanism(s) have not yet been established. Objectives : To establish a basis of understanding for anti-cancer mechanisms of herbal medicine, we profiled protein expression in human ovarian and cervical cancer cells treated with the extracts from Euonymus alatus Sieb, Oldenlandia diffusa (Willd.) Roxburgh and Orostachys japonicus A. Berger. Methods : Human ovarian cancer cell line NIH:OVCAR-3, and human cervical cancer cell line HeLa were employed in the present study. Whole protein was obtained from the cells harvested at 48 hours after the treatment with herbal water-extract, and analyzed by 2DE-based proteomic approach. Results : Various changes of protein expression induced by the herbal treatment were monitored : down-regulation of molecular chaperone (calreticulin variant), glycolytic enzymes (D-3-phosphoglycerate dehydrogenase, glyceraldehyde 3-phosphate dehydrogenase and alpha-enolase), RNA processing molecules (hnRNP A2/B1), and antioxidant protein (peroxiredoxin 1). Conclusions : Repression of glycolysis has been accepted as the mechanism to increase anticancer reagent's effect. Thus, down-regulation of glycolytic enzymes by the herbal extracts suggested a possible synergistic effect of herbs in the presence of platinum-based therapeutics. In further study, as well as the synergistic effect of the herbs, it has to be further validated whether artificial regulation of hnRNP A2/B1 in ovarian cancer cells affects various cancer survival factors, since RNA processing can be interrupted by deranged expression of hnRNP subtypes, and it results in an inhibition of cancer cell growth.

키워드

참고문헌

  1. Lee SK, Hwang JY, Song JH, Jo JR, Kim MJ, Kim ME, et al. Inhibitory activity of Euonymus alatus against alpha-glucosidase in vitro and in vivo. Nutr Res Pract. 2007;1(3):184-8. https://doi.org/10.4162/nrp.2007.1.3.184
  2. Hwang JS, Kwon HK, Lee CK, Jeon WK, Ko BS, Im SH. Development of T Cell Immunomodulators from Natural Products. Research Focus on Natural Products and the Body's Immune and Inflammatory. 2007:253-73.
  3. Ryu DS, Baek GO, Kim EY, Kim KH, Lee DS. Effects of polysaccharides derived from Orostachys japonicus A. Berger on induction of cell cycle arrest and apoptotic cell death in human colon cancer cells. BMB Rep. 2010;43(11):750-5. https://doi.org/10.5483/BMBRep.2010.43.11.750
  4. Sandra T, Hwee TT, Maxey CC. Membrane proteins and membrane proteomics. Proteomics. 2008;8(19):3924-32. https://doi.org/10.1002/pmic.200800597
  5. Ryu WJ, Choi CH. Application of Proteomics and Protein Chip Analysis in the Diagnosis of Neurodegenerative Disorders. J Korean Neurol Assoc. 2003;21(6):584-99.
  6. Wen JK. Han M. Application of genomics and proteomics in study of traditional Chinese medicine. Zhong Xi Yi Jie He Xue Bao. 2004;2(5):323-5. https://doi.org/10.3736/jcim20040502
  7. Cho WC. Application of proteomics in Chinese medicine research. Am J Chin Med. 2007;35(6):911-22. https://doi.org/10.1142/S0192415X07005375
  8. Kang YJ. Herbogenomics: from traditional Chinese medicine to novel therapeutics. Exp Biol Med (Maywood). 2008;233(9):1059-65. https://doi.org/10.3181/0802-MR-47
  9. Liu CB, Chen AH, Ding YJ, Jin HY, Seow- Choen F. The role of traditional Chinese medicine in colorectal cancer treatment. Tech Coloproctol. 2008;12(1):1-6. https://doi.org/10.1007/s10151-008-0392-z
  10. Yoon JS, Seo JC, Han SW. Pinelliae Rhizoma herbal-acupuncture solution induced apoptosis in human cervical cancer cells, SNU-17. Am J Chin Med. 2006;34(3):401-8. https://doi.org/10.1142/S0192415X0600393X
  11. Can CY, Han Y, Ren YS, Wang YL. Apoptotic B16-F1 cells coated with recombinant calreticulin mediated anti-tumor immune response in mice. Chinese Journal of Cancer Research. 2010;22(4):253-9. https://doi.org/10.1007/s11670-010-0253-y
  12. Kepp O, Tesniere A, Zitvogel L, Kroemer G. The immunogenicity of tumor cell death. Curr Opin Oncol. 2009;21(1):71-6. https://doi.org/10.1097/CCO.0b013e32831bc375
  13. Chen CN, Chang CC, Su TE, Hsu WM, Jeng YM, Ho MC, et al. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer. Ann Surg Oncol. 2009;16(2):524-33. https://doi.org/10.1245/s10434-008-0243-1
  14. Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EBMO J. 2009;28(5):578-90.
  15. Lucia C, Michela DM, Andrea U, Cristiano F, Maria BDi, Giovanni S, et al. Comparative Proteomic Analysis of Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line and Its Resistant Counterpart A2780TC1 by 2D-DIGE: The Role of ERp57. J. Proteome Res. 2009;8(4):1902-12. https://doi.org/10.1021/pr800856b
  16. Wei W, Chunlan Y, Tieer G, Zhanghui C, Xianghong L, Penelope JD, et al. Nuclear proteome analysis of cisplatin-treated HeLa cells. Muta Res. 2010; 691(2):1-8. https://doi.org/10.1016/j.mrfmmm.2010.06.002
  17. Ganapathy-Kanniappan S, Geschwind JF, Kunjithapatham R, Buijs M, Vossen JA, Tchernyshyov I, et al. Glyceraldehyde-3- phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. Anticancer Res. 2009;29(12):4909-18.
  18. Shih NY, Lai HL, Chang GC, Lin HC, Wu YC, Liu JM, et al. Anti-alpha -enolase autoantibodies are down-regulated in advanced cancer patients. Jpn J Clin Oncol. 2010;40(7):663-9. https://doi.org/10.1093/jjco/hyq028
  19. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, et al. MicroRNA 17/20 inhibits cellular inbasion and tumor metastasis in breast cancer by heterotypic signaling. Cell Biology. 2010;107(18):8231-36.
  20. Valera VA, Li-Ning-T E, Walter BA, Roberts DD, Linehan WM, Merino MJ. Protein expression profiling in the spectrum of renal cell carcinomas. J Cancer. 2010;1:184-96.
  21. Guha M, Pan H, Fang JK, Avadhani NG. Heterogeneous nuclear ribonucleoprotein A2 is a common transcriptional coactivator in the nuclear transcription response to mitochondrial respiratory stress. Mol Biol Cell. 2009;20(18):4107-19. https://doi.org/10.1091/mbc.E09-04-0296
  22. Markus HH, Gunter S. A Common Pathway for All Autoimmune Diseases? The Unholy Alliance of Environment, Cell Death and Nucleic Acids. Current Immunology Reviews. 2009;5:69-88. https://doi.org/10.2174/157339509787314387
  23. Wang X, He S, Sun JM, Delcuve GP, Davie JR. Selective association of peroxiredoxin 1 with genomic DNA and COX-2 upstream promoter elements in estrogen receptor negative breast cancer cells. Mol Biol Cell. 2010;21(17):2987-95. https://doi.org/10.1091/mbc.E10-02-0160
  24. Chhipa RR, Lee KS, Onate S, Wu Y, Ip C. Prx1 enhances androgen receptor function in prostate cancer cells by increasing receptor affinity to dihydrotestosterone. Mol Cancer Res. 2009;7(9):1543-52. https://doi.org/10.1158/1541-7786.MCR-08-0546
  25. Joshi G, Aluise CD, Cole MP, Sultana R, Pierce WM, Vore M, et al. Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stressmediated chemobrain. Neuroscience. 2010;166(3):796-807. https://doi.org/10.1016/j.neuroscience.2010.01.021